The first issue of ACC's newest JACC Journal, JACC: CardioOncology, provides a comprehensive new resource to better understand and apply evolving research surrounding the cardiovascular health of cancer patients and survivors. The quarterly, open-access journal published online Sept. 24.

Led by Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, the first issue includes seven original research papers addressing safety and efficacy of drugs in preventing cardiotoxicity; blood pressure response to inhibitors; pre-diagnosis exercise and cardiovascular events in breast cancer; and more.

In a joint Leadership Page article, ACC President Richard J. Kovacs, MD, FACC, and American Society of Clinical Oncology President Howard A. Burris III, MD, discuss how cardio-oncology is "stronger together." "As we recognize the publication of the first edition of JACC: CardioOncology, we celebrate a new tool to aid in the fight: to publish new knowledge, to educate our members, to foster debate, and to advance the frontiers of this growing field. Ultimately, we strive to improve the quality of life for the patients we serve," they explain.

In the inaugural Editor's Page, Ky gives her guiding principles and vision for the journal. "Ultimately, JACC: CardioOncology is a tremendous opportunity to shape and transform the field of cardio-oncology into a mature field that focuses on scientific evidence, patient centeredness, community engagement, and multidisciplinary collaboration," she writes.

Interested in learning more about advancing cardio-oncology? Ky also serves as a course director of the ACC's annual Cardio-Oncology course, Advancing the Cardiovascular Care of the Oncology Patient, which will be held in Washington, DC, in February 2020. Registration is now open. Abstract submission is open until Dec. 8. Learn more.

Keywords: Cardiotoxicity, Leadership, Blood Pressure, Quality of Life, Medical Oncology, Breast Neoplasms

< Back to Listings